Drug

Viloxazine clinical trials

Also written SPN-812.

studies test it: 13
open now: 1
in phase 3: 8
first study started: 2016

Keep track of what changes. Save the Viloxazine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

13 studies that test it; most in 2017 (4)

Studies that test Viloxazine, by start year
Year	Studies
2016	2
2017	4
2019	2
2020	1
2021	1
2023	1
2024	2

By phase

A phase 1/2 study counts in both.

Phase 2: 1
Phase 3: 8
Phase 4: 4

What it is tested for

Each study’s main condition, where its own words name it.

Attention Deficit Disorder with Hyperactivity: 7

Who runs them

Industry 13 · Other 0

Supernus Pharmaceuticals, Inc. (13)

Studies

Open first, then newest update. How each study uses Viloxazine is read from its arms, and is right about nine times in ten.

Testing it · 13

Codes

What other systems call Viloxazine · ClinicalTrials.gg INT008406

MeSH (NLM) D014745ViloxazineConfirmed NLM, Wikidata
UNII (FDA) 5I5Y2789ZFVILOXAZINEConfirmed FDA, NLM, Wikidata
RxNorm 11196Confirmed FDA, Wikidata
Wikidata Q907148viloxazineConfirmed FDA, NLM, Wikidata
NCI Thesaurus C152877ViloxazineOne source FDA
DrugBank DB09185One source Wikidata

System	Code	Name there	Checked by
MeSH (NLM)	D014745	Viloxazine	Confirmed NLM, Wikidata
UNII (FDA)	5I5Y2789ZF	VILOXAZINE	Confirmed FDA, NLM, Wikidata
RxNorm	11196	—	Confirmed FDA, Wikidata
Wikidata	Q907148	viloxazine	Confirmed FDA, NLM, Wikidata
NCI Thesaurus	C152877	Viloxazine	One source FDA
DrugBank	DB09185	—	One source Wikidata

Also registered as viloxazine hydrochloride (UNII OQW30I1332 · RxNorm 142143).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.